(2020) MiR-492 as an Important Biomarker for Early Diagnosis and Targeted Treatment in Different Cancers. Current Cancer Therapy Reviews. pp. 269-275. ISSN 1573-3947
Full text not available from this repository.
Abstract
Recent studies have led to a more detailed understanding of the roles played by microRNAs in health and disease, and their potential use as biomarkers in physiological and pathophysiological processes involving cancer initiation and progression. MiR-492 is encoded by a pseudogene, has a key role in some human cancer cells and its overexpression in tissues, and it has been proposed that it can be used as a good biomarker for management and early diagnosis of some cancers including breast cancer, colorectal and ovarian cancer, hepatocellular cancer, retinoblastoma and pancreatic cancer. The aim of this review was to summarize the data of MiR-492 for early diagnosis and treatment of some types of related cancers.
Item Type: | Article |
---|---|
Keywords: | MiR-492 breast cancer microRNAs colorectal cancer RNA-silencing biomarker microrna expression mirnas retinoblastoma identification proliferation genes cells Oncology |
Divisions: | |
Page Range: | pp. 269-275 |
Journal or Publication Title: | Current Cancer Therapy Reviews |
Volume: | 16 |
Number: | 4 |
Identification Number: | 10.2174/1573394716666200309124048 |
ISSN: | 1573-3947 |
Depositing User: | مهندس مهدی شریفی |
URI: | http://eprints.zbmu.ac.ir/id/eprint/3524 |
Actions (login required)
View Item |